ASME GER Week ended 07 Aug 2026

Weekly Investor Report

ASML Holding N.V. · Technology · Semiconductor Equipment & Materials

Open interactive chart View report data
Latest close 1,499 EUR
4.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.1% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 4.0%, after a -4.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 67/100.

Setup score 65 out of 100
Latest Close 1,499 EUR 7 Aug 2026
1W Return 4.0% latest completed week
4W Return -4.5% short-term follow-through
12W Return 14.7% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 48-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.0% Latest completed week; four-week move -4.5%. Indicator stack 96/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 67/100 32 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.1% above the Trend Line and sits at 83.4% of its 52-week range. The latest completed week returned 4.0%, after a -4.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9512-week average 0.95

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.5% over four weeks, 14.7% over 12 weeks, and 144.3% over one year. The current trend has remained active for 48 consecutive weeks.

Performance by holding period

1W4.0%
4W-4.5%
12W14.7%
26W26.1%
52W144.3%
Active trend streak48 weeks
Active weeks in one year48
Trend breadth92.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.32Latest activity-pressure read.
Pressure change-71.0%Four-week change in activity pressure.
Leadership23.56Latest relative-leadership reading.
RS change-46.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength53/100Blend of value, momentum, and quality. Underlying universe rank 48; rank 1 is best.
Value2/100Relative valuation strength. Underlying universe rank 99; rank 1 is best.
Quality97/100Profitability and accounting quality. Underlying universe rank 4; rank 1 is best.
Momentum98/100Medium-term price momentum. Underlying universe rank 3; rank 1 is best.
Growth93/100Revenue and earnings growth. Underlying universe rank 8; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
57.5x
Price divided by trailing earnings.
Price / sales
17.1x
Market value relative to trailing revenue.
EV / EBITDA
45.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
52.6%
Gross profit retained from each unit of revenue.
Operating margin
34.8%
Operating profit retained from revenue.
Free-cash-flow margin
26.4%
Free cash flow generated from revenue.
Return on invested capital
56.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
15.6%
Latest one-year revenue growth.
EPS growth
29.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
21.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.5%
Cash dividends relative to market value.
Buyback yield
0.7%
Net share repurchases relative to market value.
Shareholder yield
1.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment67/100

Weighted news tone is positive across 32 relevant articles.

22 positive · 7 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.6%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+11.5%Week of 12 Jun.
Worst week-7.8%Week of 31 Jul.
Latest week+4.0%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses8
Sharp losses4
Recent vol5.3%13-week weekly-return volatility.
Base vol5.1%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew5.0% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape69/100

Trend, activity pressure, participation, and risk combine to a 69/100 tape read.

 Indicator analysis85/100

Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 12/12.

Activity pressure 0.95; 2 reversal markers Factors61/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 31 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment67/100

Weighted news tone is positive across 32 relevant articles.

4 Goldman Sachs Mutual Funds to Buy for Wealth Creation Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20261,499 EUR4.0%1,337 EUR846.6 EUR0.3223.5625.9KOn
31 Jul 20261,441 EUR-7.8%1,323 EUR840.8 EUR0.6523.6168.4KOn
24 Jul 20261,563 EUR1.8%1,308 EUR835.4 EUR0.8638.7020.4KOn
17 Jul 20261,535 EUR-2.3%1,286 EUR829.5 EUR0.9739.9546.6KOn
10 Jul 20261,570 EUR-3.7%1,264 EUR823.5 EUR1.1044.0830.8KOn
3 Jul 20261,631 EUR3.6%1,243 EUR817.8 EUR1.1647.792.5KOn
26 Jun 20261,574 EUR-5.5%1,220 EUR811.3 EUR1.1151.503.9KOn
19 Jun 20261,666 EUR2.2%1,198 EUR805.4 EUR0.9460.974.3KOn
12 Jun 20261,630 EUR11.5%1,170 EUR798.7 EUR0.8062.648.6KOn
5 Jun 20261,462 EUR5.6%1,144 EUR792.4 EUR0.4147.796.6KOn
29 May 20261,384 EUR-1.7%1,125 EUR787.2 EUR0.2140.1620.4KOn
22 May 20261,409 EUR7.9%1,109 EUR782.5 EUR-0.0445.8932.7KOn
15 May 20261,306 EUR-1.0%1,092 EUR777.8 EUR-0.4242.6621.6KOn
8 May 20261,320 EUR8.4%1,077 EUR773.4 EUR-0.4343.7826.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context